Literature DB >> 29159696

Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.

Maria Infantino1, Boaz Palterer2, Roberta Biagiotti2, Fabio Almerigogna2, Maurizio Benucci3, Arianna Damiani3, Valentina Grossi4, Annalisa Azzurri5, Patrizia Casprini5, Giovanni Bacci6, Maria Grazia Giudizi2, Mariangela Manfredi4.   

Abstract

Immunofluorescence on HEp2-cells is the standard diagnostic assay for the detection of anti-nuclear antibodies (ANA). Cytoplasmic speckled patterns are a common finding, and are associated with various antibodies, including anti-synthetase antibodies. However, classic ENA testing generally identifies only anti-Jo-1. Moreover, anti-synthetase syndrome is increasingly recognized as a pleomorphic entity, possibly presenting as isolated arthritis or interstitial lung disease. Sera referred for routine ANA testing were selected on the basis of the presence of a fine dense speckled cytoplasmic pattern (254 samples) and compared to control sera with negative cytoplasm (239 samples). All 493 samples were tested with a commercial synthetase profile dot-blot (D TEK - Alphadia-Alifax) including anti-Jo1, anti-PL7, anti-PL12, anti-EJ, anti-OJ, anti-KS, anti-ZO, anti-HA, anti-SRP, and anti-Ribosome P0. Retrospective clinical data was searched for positive patients. Dot-blot identified 18/254 (7.1%) positive sera in the samples with a cytoplasmic fluorescence pattern and 4/239 (1.7%) in the control group (χ2 = 8.4627; p = 0.003625). Blot intensity was more intense in samples with concordant cytoplasmic staining (cytoplasmic negative 27 ± 12.4; cytoplasmic positive 53.9 27 ± 27.7; p = 0.0027). In the positive samples, 8/18 had a highly compatible diagnosis (myositis, interstitial lung disease, arthritis), 7/18 an uncharacterized connective tissue disease, and 3 a diagnosis not associated with the presence of anti-synthetase antibodies. We evaluated the performance of a dot-blot assay for anti-cytoplasmic antibodies in a serologic cohort presenting a cytoplasmic speckled pattern found during routine ANA testing. This algorithm enabled the identification of a significant quota of patients with rare anti-synthetase antibodies and an incomplete or atypical clinical picture. Reflex testing strategies of speckled cytoplasmic patterns with multiplex assays containing cytoplasm-specific antigens, as opposed to standard ENA testing, may yield important data and for this reason should be implemented in routine ANA testing.

Entities:  

Keywords:  Idiopathic inflammatory myopathies; Indirect immunofluorescence cytoplasmic pattern; Multiplex dot-blot assays; Myositis-specific autoantibodies

Mesh:

Substances:

Year:  2018        PMID: 29159696     DOI: 10.1007/s12026-017-8974-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  26 in total

1.  Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.

Authors:  Ilse E A Hoffman; Isabelle Peene; Eric M Veys; Filip De Keyser
Journal:  Clin Chem       Date:  2002-12       Impact factor: 8.327

2.  Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.

Authors:  Anna Ghirardello; Mariaelisa Rampudda; Louise Ekholm; Nicola Bassi; Elena Tarricone; Sandra Zampieri; Margherita Zen; Gaetano A Vattemi; Ingrid E Lundberg; Andrea Doria
Journal:  Rheumatology (Oxford)       Date:  2010-08-19       Impact factor: 7.580

3.  Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing.

Authors:  Wendy Y Craig; Thomas B Ledue; Marilyn F Collins; William E Meggison; Lynda F Leavitt; Robert F Ritchie
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

Review 4.  Commercial blot assays in the diagnosis of systemic rheumatic diseases.

Authors:  Anna Ghirardello; Raffaele Bendo; Maria Elisa Rampudda; Nicola Bassi; Sandra Zampieri; Andrea Doria
Journal:  Autoimmun Rev       Date:  2009-02-12       Impact factor: 9.754

5.  International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Nancy Agmon-Levin; Jan Damoiseaux; Cees Kallenberg; Ulrich Sack; Torsten Witte; Manfred Herold; Xavier Bossuyt; Lucille Musset; Ricard Cervera; Aresio Plaza-Lopez; Carlos Dias; Maria José Sousa; Antonella Radice; Catharina Eriksson; Olof Hultgren; Markku Viander; Munther Khamashta; Stephan Regenass; Luis Eduardo Coelho Andrade; Allan Wiik; Angela Tincani; Johan Rönnelid; Donald B Bloch; Marvin J Fritzler; Edward K L Chan; I Garcia-De La Torre; Konstantin N Konstantinov; Robert Lahita; Merlin Wilson; Olli Vainio; Nicole Fabien; Renato Alberto Sinico; Pierluigi Meroni; Yehuda Shoenfeld
Journal:  Ann Rheum Dis       Date:  2013-10-14       Impact factor: 19.103

6.  Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.

Authors:  Andrea Váncsa; Lajos Gergely; Andrea Ponyi; Gabriella Lakos; Júlia Németh; Péter Szodoray; Katalin Dankó
Journal:  Joint Bone Spine       Date:  2010-02-25       Impact factor: 4.929

7.  Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools.

Authors:  Albert Selva-O'Callaghan; Ernesto Trallero-Araguás; Maria Angeles Martínez; Moises Labrador-Horrillo; Iago Pinal-Fernández; Josep Maria Grau-Junyent; Candido Juárez
Journal:  Expert Rev Clin Immunol       Date:  2015-04-30       Impact factor: 4.473

Review 8.  The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus.

Authors:  Sandra Gofinet Pasoto; Vilma Santos Trindade Viana; Eloisa Bonfa
Journal:  Expert Rev Clin Immunol       Date:  2014-10-08       Impact factor: 4.473

9.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

10.  The cytoplasmic linker protein CLIP-170 is a human autoantigen.

Authors:  K J Griffith; J P Ryan; J-L Senécal; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

View more
  3 in total

1.  Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.

Authors:  Carolien Bonroy; Yves Piette; Yves Allenbach; Xavier Bossuyt; Jan Damoiseaux
Journal:  J Transl Autoimmun       Date:  2022-02-11

Review 2.  Bench to bedside review of myositis autoantibodies.

Authors:  Boaz Palterer; Gianfranco Vitiello; Alessia Carraresi; Maria Grazia Giudizi; Daniele Cammelli; Paola Parronchi
Journal:  Clin Mol Allergy       Date:  2018-03-07

3.  Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.

Authors:  A Sclafani; K M D'Silva; B P Little; E M Miloslavsky; J J Locascio; A Sharma; S B Montesi
Journal:  Respir Res       Date:  2019-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.